本页面由Tiger Trade Technology Pte. Ltd.提供服务

Krystal Biotech Inc.

321.16
-10.9100-3.29%
盘后:321.160.00000.00%19:30 EDT
成交量:28.13万
成交额:9,090.19万
市值:95.06亿
市盈率:40.32
高:331.93
开:331.48
低:320.95
收:332.07
52周最高:382.54
52周最低:181.44
股本:2,959.88万
流通股本:2,353.93万
量比:1.05
换手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):7.97
每股收益(LYR):6.84
净资产收益率:20.12%
总资产收益率:9.37%
市净率:6.99
市盈率(LYR):46.95

数据加载中...

2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/06

重要事件披露

Form 8-K - Current report
2023/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/07

重要事件披露

Form 8-K - Current report